Jim Graham

Jim Graham CFA is currently the Director of Investments at Research Bridge Partners and President of Tuebor Energy. Jim serves as a Board Member at Erisyon, IpiNovyx Bio, and Qana Therapeutics. Previously, Jim was the President of Strike Bio Inc and served as a Board Member at L7 Informatics and Laguna Pharmaceuticals. Throughout their career, Jim has shown a strong track record in managing businesses, acquisitions, clinical trials, and investments in the pharmaceutical and biotech industries. Jim holds a B.S. in Biological Sciences from Stanford University, a (HST) S.M. in Biomedical Sciences from Harvard Medical School, and an MBA from MIT Sloan School of Management. Jim's extensive experience and education make him a valuable asset in the field of life sciences.